review of glp 1 Cardiovascular Effects and Tolerability GLP-1 Receptor Agonists: A Systematic and Meta-Analysis of 99,599 Patients GLP-1 receptor agonists and next-generation

Description

However, more recent work has suggested that S

But they are: not a cure not metabolically neutral not a substitute for healthy lifestyle & healthspan medicine #GLP1 #CardiometabolicHealth #ObesityMedicine #PreventiveCardiology #Longevity #EvidenceBasedMedici Liesbeth Van RossumLiesbeth Van Rossum is an Influencer Professor of Medicine, internist-endocrinologist at Erasmus MC | European clinical lead obesity and diabetes at the European Society of Endocrinology 2021-2025 | obesity, stress and glucocorticoids | Linkedin Top Voice 49,762 followers

Affordability (yes, here too): While price breaks on GLP-1s may seem like a welcomed relief, prioritizing price as the main factor in using compounded formulations does not tell the whole story